Home/Filings/4/0001567619-21-022453
4//SEC Filing

Haft Nicholas 4

Accession 0001567619-21-022453

CIK 0001733257other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 6:21 PM ET

Size

5.1 KB

Accession

0001567619-21-022453

Insider Transaction Report

Form 4
Period: 2021-12-20
Transactions
  • Purchase

    Common Stock, $0.001 par value per share

    2021-12-20$10.18/sh+63,850$649,9934,056,907 total(indirect: See footnote)
Footnotes (1)
  • [F1]All shares are held indirectly by entities of which the reporting person is the manager. The reporting person has voluntarily reported the entire amount of such entities' interest. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any such securities.

Documents

1 file

Issuer

Finch Therapeutics Group, Inc.

CIK 0001733257

Entity typeother

Related Parties

1
  • filerCIK 0001850404

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 6:21 PM ET
Size
5.1 KB